Skip to content

Elite Pharmaceuticals, Inc.: filings

Every Elite Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 63 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q1 202748960001493152-26-037752
10-K2026-06-29fiscal FY 202650990001493152-26-031070
10-Q2026-02-17fiscal Q3 2026481380001493152-26-007104
10-Q2025-11-14fiscal Q2 2026481340001493152-25-023477
10-Q2025-08-14fiscal Q1 202647950001493152-25-011989
10-K2025-06-30fiscal FY 2025501000001641172-25-017134
10-Q2025-02-13fiscal Q3 2025501450001493152-25-006427
10-Q2024-11-14fiscal Q2 2025501390001493152-24-045933
10-Q2024-08-14fiscal Q1 202550970001493152-24-032154
10-K2024-07-01fiscal FY 2024521030001493152-24-025829
10-Q2024-02-14fiscal Q3 2024491440001493152-24-006661
10-Q2023-11-14fiscal Q2 2024481360001493152-23-041124
10-Q2023-08-14fiscal Q1 202447930001493152-23-028434
10-K2023-06-29fiscal FY 202351990001493152-23-022936
10-Q2023-02-14fiscal Q3 2023471370001493152-23-004896
10-Q2022-11-14fiscal Q2 2023481350001493152-22-032117
10-Q2022-08-15fiscal Q1 202347940001493152-22-022928
10-K2022-06-29fiscal FY 202250970001493152-22-018108
10-Q2022-02-14fiscal Q3 2022481380001493152-22-004471
10-Q2021-11-15fiscal Q2 2022471360001493152-21-028584
10-Q2021-08-16fiscal Q1 202245940001493152-21-020176
10-K2021-06-14fiscal FY 202148960001213900-21-032329
10-Q2021-02-16fiscal Q3 2021481410001213900-21-009615
10-Q2020-11-16fiscal Q2 2021491380001213900-20-037339
10-Q2020-08-14fiscal Q1 202149990001213900-20-022244
10-K2020-06-29fiscal FY 202050990001213900-20-016181
10-Q2020-02-10fiscal Q3 2020481400001213900-20-003097
10-Q2019-11-12fiscal Q2 2020481350001213900-19-022960
10-Q2019-08-09fiscal Q1 202047980001213900-19-015154
10-K2019-06-21fiscal FY 201947950001213900-19-011224
10-Q2019-02-11fiscal Q3 2019471300001213900-19-002097
10-Q2018-11-09fiscal Q2 2019441200001144204-18-058784
10-Q2018-08-09fiscal Q1 201946940001144204-18-043318
10-K2018-06-14fiscal FY 2018452370001144204-18-034237
10-Q2018-02-09fiscal Q3 2018431220001144204-18-006977
10-Q2017-11-09fiscal Q2 2018421180001144204-17-057793
10-Q2017-08-09fiscal Q1 201840820001144204-17-041706
10-K2017-06-14fiscal FY 2017412250001144204-17-032547
10-Q2017-02-09fiscal Q3 2017401160001144204-17-007071
10-Q2016-11-09fiscal Q2 2017401160001144204-16-132825
10-Q2016-08-09fiscal Q1 201740820001144204-16-117691
10-K2016-06-15fiscal FY 2016422280001144204-16-108327
10-Q2016-02-09fiscal Q3 2016371070001144204-16-079982
10-Q2015-12-30fiscal Q2 2016371070001144204-15-073388
10-Q2015-12-30fiscal Q1 201635720001144204-15-073381
10-Q2015-11-09fiscal Q2 2016371070001144204-15-063796
10-Q2015-08-10fiscal Q1 201634700001144204-15-047733
10-K2015-06-15fiscal FY 201537770001144204-15-037217
10-Q2015-02-17fiscal Q3 2015361060001144204-15-010251
10-Q2014-11-14fiscal Q2 2015371080001144204-14-068797
10-Q2014-08-14fiscal Q1 201536740001144204-14-050155
10-K2014-06-30fiscal FY 201437770001144204-14-040327
10-Q2014-02-14fiscal Q3 2013391140001144204-14-008935
10-Q2013-11-14fiscal Q2 2013391130001144204-13-061851
10-Q2013-08-14fiscal Q1 201337750001144204-13-045859
10-K2013-06-21fiscal FY 201239810001144204-13-036025
10-Q2013-02-14fiscal Q3 2012381120001144204-13-009129
10-Q2012-11-14fiscal Q2 2012381110001144204-12-062633
10-Q2012-08-14fiscal Q1 201237750001144204-12-045619
10-K2012-06-29fiscal FY 201130620001144204-12-037392
10-Q2012-02-14fiscal Q3 2011361040001144204-12-008039
10-Q2011-11-14fiscal Q2 2011351000001144204-11-063703
10-Q/A2011-08-19fiscal Q1 201132660001144204-11-048614

Inspect the source

Entity
Elite Pharmaceuticals, Inc. / CIK 0001053369
Captured
2026-09-20T05:17:33.154Z
SEC response SHA-256
b91e0331a01f96870ee44e841f605bd504e1bc784022b77f374cfe93dc363314

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001053369.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))